Tygh Capital Management’s iRadimed IRMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-69,045
Closed -$1.32M 92
2016
Q1
$1.32M Sell
69,045
-69,021
-50% -$1.32M 0.39% 87
2015
Q4
$3.87M Buy
+138,066
New +$3.9M 1.09% 42

Other funds holding IRMD

Tygh Capital Management's IRMD Position: Q2 2016 in Review

Tygh Capital Management sold out of iRadimed (IRMD) in Q2 2016, closing a stake of 69,045 shares — an estimated $1.32M sold.

Tygh Capital Management first reported a position in IRMD in Q4 2015 and held it in 2 quarters. The position peaked at $3.87M in Q4 2015. 60 funds tracked by Wall St. Rank hold IRMD as of Q2 2016.

  • Tygh Capital Management reported no remaining iRadimed position as of Q2 2016 after selling out during the quarter.
  • Tygh Capital Management sold 69,045 iRadimed shares in Q2 2016, an estimated $1.32M.
  • Tygh Capital Management first reported a position in iRadimed in Q4 2015 and held it in 2 quarters.
  • Tygh Capital Management's iRadimed position peaked at $3.87M in Q4 2015.
  • 60 funds tracked by Wall St. Rank held iRadimed as of Q2 2016.

Based on Tygh Capital Management's 13F filing for Q2 2016, filed 4 Aug 2016.